Seek Returns logo

EW vs. ICLR: A Head-to-Head Stock Comparison

Updated on

Here’s a clear look at EW and ICLR, comparing key factors like historical performance, profitability, financial strength, growth, dividend, and valuation.

Company Profile

SymbolEWICLR
Company NameEdwards Lifesciences CorporationICON Public Limited Company
CountryUnited StatesIreland
GICS SectorHealth CareHealth Care
GICS IndustryHealth Care Equipment & SuppliesLife Sciences Tools & Services
Market Capitalization44.95 billion USD14.81 billion USD
ExchangeNYSENasdaqGS
Listing DateMarch 27, 2000May 15, 1998
Security TypeCommon StockCommon Stock

Historical Performance

This chart compares the performance of EW and ICLR by tracking the growth of an initial $10,000 investment in each. Use the tabs to select the desired time period. Data is adjusted for dividends and splits.

EW vs. ICLR: Growth of a $10,000 investment over the past one year.

Historical Performance at a Glance

SymbolEWICLR
5-Day Price Return-1.56%8.82%
13-Week Price Return-0.17%29.03%
26-Week Price Return6.53%14.33%
52-Week Price Return17.12%-35.05%
Month-to-Date Return-1.56%8.82%
Year-to-Date Return3.42%-9.19%
10-Day Avg. Volume4.57M0.92M
3-Month Avg. Volume4.28M1.24M
3-Month Volatility20.28%62.96%
Beta0.961.27

Profitability

Return on Equity (TTM)

EW

41.25%

Health Care Equipment & Supplies Industry

Max
29.93%
Q3
16.99%
Median
9.28%
Q1
5.10%
Min
-12.52%

EW’s Return on Equity of 41.25% is exceptionally high, placing it well beyond the typical range for the Health Care Equipment & Supplies industry. This demonstrates a superior ability to generate profit from shareholder investments, though it could also be inflated by high financial leverage.

ICLR

8.28%

Life Sciences Tools & Services Industry

Max
19.96%
Q3
11.51%
Median
6.47%
Q1
3.86%
Min
-6.95%

ICLR’s Return on Equity of 8.28% is on par with the norm for the Life Sciences Tools & Services industry, indicating its profitability relative to shareholder equity is typical for the sector.

EW vs. ICLR: A comparison of their Return on Equity (TTM) against their respective Health Care Equipment & Supplies and Life Sciences Tools & Services industry benchmarks.

Net Profit Margin (TTM)

EW

72.96%

Health Care Equipment & Supplies Industry

Max
24.41%
Q3
13.71%
Median
10.08%
Q1
5.96%
Min
-5.58%

EW’s Net Profit Margin of 72.96% is exceptionally high, placing it well beyond the typical range for the Health Care Equipment & Supplies industry. This demonstrates outstanding operational efficiency and a strong competitive advantage in converting revenue into profit.

ICLR

9.82%

Life Sciences Tools & Services Industry

Max
32.18%
Q3
18.30%
Median
10.19%
Q1
4.20%
Min
-2.05%

ICLR’s Net Profit Margin of 9.82% is aligned with the median group of its peers in the Life Sciences Tools & Services industry. This indicates its ability to convert revenue into profit is typical for the sector.

EW vs. ICLR: A comparison of their Net Profit Margin (TTM) against their respective Health Care Equipment & Supplies and Life Sciences Tools & Services industry benchmarks.

Operating Profit Margin (TTM)

EW

25.01%

Health Care Equipment & Supplies Industry

Max
31.09%
Q3
18.11%
Median
15.07%
Q1
8.48%
Min
-0.28%

An Operating Profit Margin of 25.01% places EW in the upper quartile for the Health Care Equipment & Supplies industry. This signals a strong ability to translate revenue into operating profit, outperforming most of its competitors in core business efficiency.

ICLR

12.50%

Life Sciences Tools & Services Industry

Max
38.39%
Q3
21.40%
Median
13.57%
Q1
8.38%
Min
-3.51%

ICLR’s Operating Profit Margin of 12.50% is around the midpoint for the Life Sciences Tools & Services industry, indicating that its efficiency in managing core business operations is typical for the sector.

EW vs. ICLR: A comparison of their Operating Profit Margin (TTM) against their respective Health Care Equipment & Supplies and Life Sciences Tools & Services industry benchmarks.

Profitability at a Glance

SymbolEWICLR
Return on Equity (TTM)41.25%8.28%
Return on Assets (TTM)31.58%4.71%
Net Profit Margin (TTM)72.96%9.82%
Operating Profit Margin (TTM)25.01%12.50%
Gross Profit Margin (TTM)78.87%28.65%

Financial Strength

Current Ratio (MRQ)

EW

4.68

Health Care Equipment & Supplies Industry

Max
5.19
Q3
3.00
Median
2.13
Q1
1.44
Min
0.86

EW’s Current Ratio of 4.68 is in the upper quartile for the Health Care Equipment & Supplies industry. This signifies a strong liquidity position, suggesting the company is well-equipped to cover its immediate liabilities compared to its peers.

ICLR

1.29

Life Sciences Tools & Services Industry

Max
3.46
Q3
2.78
Median
1.91
Q1
1.53
Min
0.43

ICLR’s Current Ratio of 1.29 falls into the lower quartile for the Life Sciences Tools & Services industry. This indicates a tighter liquidity situation and a more constrained capacity to handle short-term debt than many of its competitors.

EW vs. ICLR: A comparison of their Current Ratio (MRQ) against their respective Health Care Equipment & Supplies and Life Sciences Tools & Services industry benchmarks.

Debt-to-Equity Ratio (MRQ)

EW

0.06

Health Care Equipment & Supplies Industry

Max
1.61
Q3
0.76
Median
0.45
Q1
0.14
Min
0.00

Falling into the lower quartile for the Health Care Equipment & Supplies industry, EW’s Debt-to-Equity Ratio of 0.06 points to a conservative financing strategy. This results in lower financial risk but potentially limits strategic investments compared to more leveraged competitors.

ICLR

0.36

Life Sciences Tools & Services Industry

Max
1.35
Q3
0.74
Median
0.41
Q1
0.18
Min
0.00

ICLR’s Debt-to-Equity Ratio of 0.36 is typical for the Life Sciences Tools & Services industry, indicating its use of leverage is in line with the sector norm. This suggests a balanced approach to its capital structure.

EW vs. ICLR: A comparison of their Debt-to-Equity Ratio (MRQ) against their respective Health Care Equipment & Supplies and Life Sciences Tools & Services industry benchmarks.

Interest Coverage Ratio (TTM)

EW

3.15

Health Care Equipment & Supplies Industry

Max
56.35
Q3
25.56
Median
9.60
Q1
3.78
Min
-26.49

In the lower quartile for the Health Care Equipment & Supplies industry, EW’s Interest Coverage Ratio of 3.15 indicates a tighter cushion for servicing debt, suggesting less financial flexibility than many of its competitors.

ICLR

4.80

Life Sciences Tools & Services Industry

Max
45.00
Q3
27.84
Median
7.16
Q1
2.12
Min
-14.08

ICLR’s Interest Coverage Ratio of 4.80 is positioned comfortably within the norm for the Life Sciences Tools & Services industry, indicating a standard and healthy capacity to cover its interest payments.

EW vs. ICLR: A comparison of their Interest Coverage Ratio (TTM) against their respective Health Care Equipment & Supplies and Life Sciences Tools & Services industry benchmarks.

Financial Strength at a Glance

SymbolEWICLR
Current Ratio (MRQ)4.681.29
Quick Ratio (MRQ)3.791.24
Debt-to-Equity Ratio (MRQ)0.060.36
Interest Coverage Ratio (TTM)3.154.80

Growth

Revenue Growth

EW vs. ICLR: A side-by-side comparison of their Revenue Growth for the MRQ (YoY), TTM (YoY), 3-Year CAGR, and 5-Year CAGR periods.

EPS Growth

EW vs. ICLR: A side-by-side comparison of their EPS Growth for the MRQ (YoY), TTM (YoY), 3-Year CAGR, and 5-Year CAGR periods.

Dividend

Dividend Yield (TTM)

EW

0.00%

Health Care Equipment & Supplies Industry

Max
4.15%
Q3
1.76%
Median
0.79%
Q1
0.00%
Min
0.00%

EW currently does not pay a dividend, resulting in a yield of 0%. This is a common strategy for growth-focused companies that prioritize reinvesting earnings, though it may be less typical in mature, income-oriented sectors.

ICLR

0.00%

Life Sciences Tools & Services Industry

Max
1.41%
Q3
0.65%
Median
0.35%
Q1
0.00%
Min
0.00%

ICLR currently does not pay a dividend, resulting in a yield of 0%. This is a common strategy for growth-focused companies that prioritize reinvesting earnings, though it may be less typical in mature, income-oriented sectors.

EW vs. ICLR: A comparison of their Dividend Yield (TTM) against their respective Health Care Equipment & Supplies and Life Sciences Tools & Services industry benchmarks.

Dividend Payout Ratio (TTM)

EW

0.00%

Health Care Equipment & Supplies Industry

Max
160.00%
Q3
66.60%
Median
27.49%
Q1
0.00%
Min
0.00%

EW has a Dividend Payout Ratio of 0%, indicating it does not currently pay a dividend. This is a common strategy for growth-oriented companies that reinvest all profits back into the business.

ICLR

0.00%

Life Sciences Tools & Services Industry

Max
113.14%
Q3
61.34%
Median
17.74%
Q1
0.00%
Min
0.00%

ICLR has a Dividend Payout Ratio of 0%, indicating it does not currently pay a dividend. This is a common strategy for growth-oriented companies that reinvest all profits back into the business.

EW vs. ICLR: A comparison of their Dividend Payout Ratio (TTM) against their respective Health Care Equipment & Supplies and Life Sciences Tools & Services industry benchmarks.

Dividend at a Glance

SymbolEWICLR
Dividend Yield (TTM)0.00%0.00%
Dividend Payout Ratio (TTM)0.00%0.00%

Valuation

Price-to-Earnings Ratio (TTM)

EW

10.93

Health Care Equipment & Supplies Industry

Max
67.29
Q3
47.01
Median
30.94
Q1
23.91
Min
10.79

In the lower quartile for the Health Care Equipment & Supplies industry, EW’s P/E Ratio of 10.93 suggests the stock may be undervalued compared to its peers, potentially presenting an attractive entry point for investors.

ICLR

18.88

Life Sciences Tools & Services Industry

Max
75.35
Q3
51.00
Median
32.93
Q1
25.27
Min
1.43

In the lower quartile for the Life Sciences Tools & Services industry, ICLR’s P/E Ratio of 18.88 suggests the stock may be undervalued compared to its peers, potentially presenting an attractive entry point for investors.

EW vs. ICLR: A comparison of their Price-to-Earnings Ratio (TTM) against their respective Health Care Equipment & Supplies and Life Sciences Tools & Services industry benchmarks.

Price-to-Sales Ratio (TTM)

EW

7.97

Health Care Equipment & Supplies Industry

Max
9.49
Q3
5.41
Median
2.86
Q1
2.07
Min
0.74

EW’s P/S Ratio of 7.97 is in the upper echelon for the Health Care Equipment & Supplies industry. This means the company is valued richly on its revenue stream compared to its peers, suggesting the stock is priced for a high level of future performance.

ICLR

1.85

Life Sciences Tools & Services Industry

Max
10.49
Q3
6.43
Median
4.66
Q1
2.88
Min
1.08

In the lower quartile for the Life Sciences Tools & Services industry, ICLR’s P/S Ratio of 1.85 indicates its revenue is valued more conservatively than most of its peers. This could present a compelling opportunity if the market has overlooked its sales-generating capabilities.

EW vs. ICLR: A comparison of their Price-to-Sales Ratio (TTM) against their respective Health Care Equipment & Supplies and Life Sciences Tools & Services industry benchmarks.

Price-to-Book Ratio (MRQ)

EW

4.35

Health Care Equipment & Supplies Industry

Max
10.85
Q3
6.56
Median
3.53
Q1
2.36
Min
0.71

EW’s P/B Ratio of 4.35 is within the conventional range for the Health Care Equipment & Supplies industry. This shows a balanced market view, where the stock’s price is neither at a significant premium nor a discount to the book value of its peers.

ICLR

1.21

Life Sciences Tools & Services Industry

Max
6.69
Q3
5.00
Median
3.46
Q1
2.38
Min
0.93

ICLR’s P/B Ratio of 1.21 is in the lower quartile for the Life Sciences Tools & Services industry. From a value investing perspective, this is favorable, as it suggests the stock is trading at a discount to its net asset value and may offer a greater margin of safety.

EW vs. ICLR: A comparison of their Price-to-Book Ratio (MRQ) against their respective Health Care Equipment & Supplies and Life Sciences Tools & Services industry benchmarks.

Valuation at a Glance

SymbolEWICLR
Price-to-Earnings Ratio (TTM)10.9318.88
Price-to-Sales Ratio (TTM)7.971.85
Price-to-Book Ratio (MRQ)4.351.21
Price-to-Free Cash Flow Ratio (TTM)59.6615.15